Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool July 18, 2008 Brian Orelli	St. Jude Is a Fighter The medical device maker continues to kick the competition while it's down.
The Motley Fool April 20, 2005 Stephen D. Simpson	St. Jude's Healthy Heartbeat Medical device maker St. Jude continues to be boosted by ICD market share gains, and new businesses are coming on line, as well.
BusinessWeek March 22, 2004 Robert Barker	St. Jude: An Insider Sign To Investors? St. Jude, the patron saint of lost causes, rarely has needed to look out for his namesake, St. Jude Medical (STJ ). Since its birth in 1976, this maker of artificial heart valves, defibrillators, catheters, and sundry other cardiac devices has led a blessed life. It's in excellent health today. So why are insiders dumping the stock?
The Motley Fool October 19, 2007 Billy Fisher	Keeping Pace at St. Jude Medical device maker St. Jude Medical has a strong quarter, but investors weren't impressed.
The Motley Fool October 17, 2005 Stephen D. Simpson	A Busy Day for St. Jude In addition to announcing a major acquisition, St. Jude also reported very solid financial results for the third quarter. Analysts keep raising the bar, and the medical equipment company continues to surpass it.
The Motley Fool July 20, 2005 Stephen D. Simpson	Hey, Jude! Party Hearty St. Jude's ICD (implantable cardioverter defibrillator) business is on fire and fueling strong profit growth for this medical device maker. Whether your cut-off makes St. Jude a mid-cap or a large-cap, this company is certainly growing -- and the stock's valuation reflects that.
The Motley Fool January 26, 2005 Stephen D. Simpson	St. Jude Is No Lost Cause The No. 3 cardiology company posts solid growth because of continuing implantable cardioverter defibrillator (ICD) market share gains.
The Motley Fool July 19, 2006 Stephen D. Simpson	Taking St. Jude's Pulse The ICD market is a long-term opportunity, but not a panacea. St. Jude investors should remember that this is a rough neighborhood -- product liability, FDA bureaucracy, and huge, tough competitors live here, too.
The Motley Fool April 19, 2007 Billy Fisher	A Saintly Quarter Shares of St. Jude Medical rise after the company announces a big quarter.
The Motley Fool January 25, 2006 Stephen D. Simpson	Is St. Jude Next to Be Wooed? Can St. Jude build upon the jump-start opportunity from Guidant's troubles, or will further market share growth prove to be increasingly hard to come by? Investors, take note.
The Motley Fool April 23, 2011	St. Jude, Medtronic Execs Offer Different Views on JAMA Article's Impact An article and government investigation into implant devices may or may not have played a role in each company's performance, depending on whom you ask.
The Motley Fool April 19, 2006 Stephen D. Simpson	St. Jude Lives and Learns Though dynamics in the ICD market caught it by surprise, this is still a quality med-tech company. Investors, take note.
InternetNews December 7, 2005 Colin C. Haley	Microsoft Plans Another $1.7B For India The company will put more money into India in hopes of getting more software out of it.
The Motley Fool April 5, 2006 Stephen D. Simpson	St. Jude's Racing Heartbeat Slows Even though the stock got far too expensive, this is still a good company and could still be a viable target for certain large health-care companies that may be in an acquisition frame of mind.
The Motley Fool January 9, 2007 Billy Fisher	St. Jude's Juiced-Up Q4 The medical-device maker shows stronger vital signs. Investors, take note.
The Motley Fool June 24, 2009 Brian Orelli	Boston Scientific Helps Itself ... and Its Rivals Boston Scientific released positive results from a clinical trial testing its heart devices, but unfortunately the data is likely to help its competitors as well.
The Motley Fool July 25, 2011 Jason Moser	Rising Star Buy: St. Jude Medical It's a good time to jump in on this medical-device maker.
Global Services June 10, 2008 Shyamanuja Das	Outsourcing to India: 1998 Vs. 2008 If you want to offshore to India for the same reasons some of your peers did in 1998, then do so at your own risk.
BusinessWeek June 7, 2004 Gene G. Marcial	St. Jude's Bruise Should Clear Up Fast St. Jude Medical (STJ ) tumbled 2%, to $73, after it revealed that the FDA had delayed for a month the approval of its new Epic CRT-defibrillator.
The Motley Fool April 25, 2011 Arundhati Parmar	St. Jude: New Aortic Replacement Valve Approved St. Jude gets good news.
InternetNews December 6, 2005 Colin C. Haley	Microsoft Plans 30 New R&D Centers Microsoft Chairman Bill Gates kicked off a four-day India trip by outlining a plan to build 30 new innovation centers around the world, including one in the tech-heavy Indian city of Bangalore.
Global Services January 28, 2008	India's Two Worlds There are two different faces of India one that is healthy, educated and technically sound and the other which is quite the opposite.
Commercial Investment Real Estate Jan/Feb 2006 Sara Drummond	India Calls U.S. commercial real estate companies are picking up on the vast opportunities in India's growing market.
The Motley Fool February 8, 2006 Tim Beyers	Who's Buying Now? Sometimes, insiders are buying for all the right reasons. Who's buying now? Dominion Resources... Goodrich Petroleum... iPass... ITT Educational Services... St. Jude Medical...
The Motley Fool April 11, 2008 Brian Orelli	St. Jude's Heartfelt Acquisition Medical-device maker St. Jude purchases tiny EP MedSystems.
Chemistry World February 20, 2013 Laura Howes	UK-India projects launched To coincide with the prime minister's visit to India, UK universities have announced a series of research partnerships and scholarships intended to boost the trade and education links between the UK and India.
InternetNews November 16, 2005 Colin C. Haley	Motorola: Made in India Motorola today made three announcements that underline the importance of India as both a manufacturing hub and an emerging market.
BusinessWeek March 19, 2007 Steve Hamm	Building Opportunity in India By putting $10 billion into India's infrastructure, Cayman Islands-based real estate investor Trikona Capital plans to do well by doing good.
The Motley Fool January 25, 2011 Jason Moser	Finding Large Caps for a Winning Portfolio A screen for six large-cap ideas, picking two to add to the watchlist.
The Motley Fool January 18, 2012 Dan Caplinger	Has St. Jude Medical Become the Perfect Stock? St. Jude took a big step toward perfection when it initiated a big dividend in early 2011.
The Motley Fool October 20, 2009 Robert Steyer	The Heart Company's Disheartening Forecast Boston Scientific scaled back its full-year forecast, and the market doesn't like it.
The Motley Fool February 17, 2009 Brian Orelli	Investors Heart Medtronic The leaner company is more lovable.
The Motley Fool July 25, 2011 Jordan DiPietro	Should You Retire With St. Jude? I can't decide for you whether or not this is the best stock for retirement, but it has passed all four tests, which is pretty impressive.
The Motley Fool October 17, 2005 Stephen D. Simpson	A Stimulating Merger St. Jude will be paying $61.25 a share in cash for Advanced Neuromodulation Systems, a robust 30% premium to Friday's closing price. This deal demonstrates that large med-tech players may still be on the prowl for avenues into fast-growing new markets.
Investment Advisor October 2010 Savita Iyer-Ahrestani	Jewels in the Crown As wealth mushrooms in India, the need for Western-style advice grows
BusinessWeek September 3, 2007 Manjeet Kripalani	A Red-Hot Big Blue In India From inking deals to hiring the best workers, IBM is leading its tech services rivals in India.
The Motley Fool January 4, 2011 Nick Kapur	India's Newest Motley Fool India's economy is growing at near double-digit rates. Its budding middle class is multiplying at incredible speeds. IPO markets are hot. And so this Motley Fool writer will be reporting directly from India.
Inc. February 2006 Darren Dahl	India Snaps Up U.S. Firms The acquisition of American companies by Indian firms pass the $1 billion mark in 2005.
Global Services September 14, 2007 Rinku Tyagi	Great Paymasters, Not Best Employers! In the Indian tech industry, employee satisfaction is no longer a derivative of higher salaries.
The Motley Fool January 22, 2010 Tim Hanson	The Biggest Investment Opportunity This Year Why power is the way to play India.
The Motley Fool July 12, 2011 Arundhati Parmar	FDA Allows Expansion of St. Jude Study to Treat Severe Depression St. Jude moves forward with treatment for depression.
BusinessWeek March 19, 2007 Nandini Lakshman	The Miracle-Worker of the Delhi Metro How an uncommon bureaucrat personally secured foreign funding and the cooperation of government agencies to build the Indian city's subway system.
The Motley Fool November 9, 2005 Stephen D. Simpson	Greatbatch Keeps Growth Pumping Demand for implantable medical electronics keeps this battery and component maker humming. Investors new to this stock and/or medical technology in general will need to exercise some patience.
InternetNews October 7, 2005 Colin C. Haley	VC Earmarks $200M For Indian IT Startups Draper Fisher Jurvetson bets that the country has more to offer than outsourcing. Other VCs are also taking interest on entrepreneurship in India.
Global Services May 3, 2007 Bhambal & Sengupta	India's Emerging Cities The new Indian cities that are servicing American corporates are ones that you may not have even heard of.
The Motley Fool October 12, 2004 Jeff Hwang	The Phantom Stock Split "Boost" If St. Jude Medical's stock went up, it's not because it's worth any more.
BusinessWeek June 19, 2006 Kripalani & Burrows	India: Why Apple Walked Away Plans for Apple's Indian tech support center have been scrapped.
IEEE Spectrum June 2007 Seema Singh	Delhi's Defense Spending Spree As India upgrades its arsenal, U.S. military contractors hope to cash in.
BusinessWeek July 1, 2010 Sharma & Nair	Finally, a Modern Passage to India New Delhi gets a terminal worthy of Hong Kong or Dubai.
The Motley Fool June 27, 2011 Arundhati Parmar	St. Jude Medical's Migraine Treatment: Good for Europe, but Not the U.S.? St. Jude won't comment on whether the company plans to do a second clinical trial or whether it is confident it will win approval from the FDA without it.